Clinical trial
Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin…
NCT00188773 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188773 |
|---|---|
| Title | Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insulin Resistance Syndrome X, Pancreatic Beta Cell Function |
| Intervention type | Drug |
| Interventions | N-acetylcysteine, intralipid, heparin |
| Enrollment | 15 |
| Start date | Jan 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 5, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: